Beijing Strong Biotechnologies,Inc. (SHE:300406)
China · Delayed Price · Currency is CNY 11.65
-0.30 (-2.51%)
Jun 8, 2026, 3:04 PM CST
SHE:300406 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Net Income | 212.22 | 189.87 | 538.29 | 523.74 | 389.1 | 405.65 |
Depreciation & Amortization | 69.42 | 69.42 | 71 | 56.21 | 54.82 | 43.62 |
Other Amortization | 2.68 | 2.68 | 1.17 | 0.96 | 0.88 | 1.87 |
Loss (Gain) From Sale of Assets | 2.87 | 2.87 | 2.11 | 3.5 | 2.68 | -0.16 |
Asset Writedown & Restructuring Costs | 175.6 | 175.6 | 1.38 | 0.21 | 5.32 | 0.11 |
Loss (Gain) From Sale of Investments | -12.14 | -12.14 | -9.61 | -20.76 | -19.08 | -11.53 |
Provision & Write-off of Bad Debts | 26.35 | 26.35 | 3.39 | 23.44 | 39.15 | 37.13 |
Other Operating Activities | 58.92 | 56.71 | 48.04 | 52.17 | 60.23 | 83.8 |
Change in Accounts Receivable | 100.07 | 100.07 | 15.81 | -69.02 | -84.94 | -184.23 |
Change in Inventory | 20.9 | 20.9 | -16.2 | -13.21 | -11.24 | -31.01 |
Change in Accounts Payable | -57.58 | -57.58 | -31.88 | 37.36 | -33.21 | 8.5 |
Operating Cash Flow | 589.67 | 565.11 | 614.01 | 585.09 | 396.17 | 341.1 |
Operating Cash Flow Growth | -11.65% | -7.96% | 4.94% | 47.69% | 16.14% | 177.18% |
Capital Expenditures | -31.21 | -39.24 | -67.65 | -148.03 | -96.48 | -65.2 |
Sale of Property, Plant & Equipment | -0.02 | 0.06 | 0.21 | 1.03 | - | 0.23 |
Cash Acquisitions | - | - | - | - | -1.44 | - |
Investment in Securities | -296.58 | -386.71 | -73.28 | 15 | -341.28 | -1,256 |
Other Investing Activities | -57.75 | -49.43 | 122.1 | 4.79 | -1.63 | 8.9 |
Investing Cash Flow | -385.56 | -475.32 | -18.62 | -127.21 | -440.82 | -1,312 |
Long-Term Debt Issued | - | 1.32 | 23.2 | 106.59 | 1,290 | 1,122 |
Long-Term Debt Repaid | - | -129.35 | -33.48 | -104.44 | -1,154 | -302.34 |
Net Debt Issued (Repaid) | -127.96 | -128.04 | -10.28 | 2.15 | 136.16 | 819.94 |
Issuance of Common Stock | - | - | 3.21 | 37.09 | - | 37.33 |
Repurchase of Common Stock | -18.79 | -18.79 | -44.66 | -49.45 | -51.1 | - |
Common Dividends Paid | -536.95 | -537.14 | -124.19 | -64.66 | -90.65 | -78.61 |
Other Financing Activities | 3.3 | 3.15 | -0.55 | 0.12 | -4.99 | -1.98 |
Financing Cash Flow | -680.4 | -680.81 | -176.48 | -74.76 | -10.58 | 776.67 |
Foreign Exchange Rate Adjustments | -0.55 | -0.39 | 0.52 | 0.2 | 1.03 | -0.36 |
Net Cash Flow | -476.84 | -591.41 | 419.43 | 383.32 | -54.21 | -194.67 |
Free Cash Flow | 558.46 | 525.87 | 546.36 | 437.06 | 299.69 | 275.9 |
Free Cash Flow Growth | -10.22% | -3.75% | 25.01% | 45.84% | 8.63% | 160.74% |
Free Cash Flow Margin | 40.75% | 38.80% | 32.93% | 25.09% | 19.84% | 17.25% |
Free Cash Flow Per Share | 0.94 | 0.89 | 0.91 | 0.73 | 0.49 | 0.47 |
Cash Income Tax Paid | 200.7 | 197.68 | 197.19 | 189.57 | 162.92 | 165.81 |
Levered Free Cash Flow | 122.8 | 309.84 | 338 | 293.07 | 157.06 | 211.82 |
Unlevered Free Cash Flow | 154.01 | 340.74 | 367.75 | 322.44 | 189.96 | 225.32 |
Change in Working Capital | 53.72 | 53.72 | -41.76 | -54.37 | -136.93 | -219.38 |